188 related articles for article (PubMed ID: 2484927)
1. [Fetal hemoglobin].
Rokicka-Piotrowicz M
Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
[TBL] [Abstract][Full Text] [Related]
2. Gene switching -- a new therapeutic epoch: discussion paper.
Nalbandian RM; Cypress GC
J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499
[No Abstract] [Full Text] [Related]
3. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
4. [Anomalies of hemoglobin synthesis as a cause of disease in childhood].
Russo G
Pediatria (Napoli); 1967; 75(3):369-99. PubMed ID: 4886665
[No Abstract] [Full Text] [Related]
5. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
Pearson HA
Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
[No Abstract] [Full Text] [Related]
6. 5-Azacytidine and fetal hemoglobin.
Heller P; DeSimone J
Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
[TBL] [Abstract][Full Text] [Related]
7. alpha-Thalassemia and HbF concentration in sickle cell anemia.
Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
[No Abstract] [Full Text] [Related]
8. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
Platt OS
Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
Yang YM; Pace B
Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
[TBL] [Abstract][Full Text] [Related]
10. Disorders of the synthesis of human fetal hemoglobin.
Manca L; Masala B
IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
[TBL] [Abstract][Full Text] [Related]
11. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
12. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
Dover GJ; Charache S
Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
[TBL] [Abstract][Full Text] [Related]
13. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
Dover GJ; Charache S; Boyer SH
Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
[No Abstract] [Full Text] [Related]
14. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
15. The effects of variable doses of 5-azacytidine on fetal hemoglobin production in sickle cell anemia.
Dover GJ; Charache SH
Prog Clin Biol Res; 1984; 165():73-83. PubMed ID: 6209731
[No Abstract] [Full Text] [Related]
16. The human fetal hemoglobins.
Huisman TH
Tex Rep Biol Med; 1980-1981; 40():29-42. PubMed ID: 6172867
[No Abstract] [Full Text] [Related]
17. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
[No Abstract] [Full Text] [Related]
18. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
Dover GJ; Charache S
Prog Clin Biol Res; 1987; 240():277-85. PubMed ID: 2441416
[No Abstract] [Full Text] [Related]
19. Fetal hemoglobin.
Cooper HA; Hoagland HC
Mayo Clin Proc; 1972 Jun; 47(6):402-14. PubMed ID: 4557458
[No Abstract] [Full Text] [Related]
20. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
Coleman E; Inusa B
Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
